New approaches to the antibiotic resistance problem

By Derry K Mercer, Principal Scientist at Novabiotics Ltd & member of the Biochemical Society Policy Advisory Panel

methicillin-resistant_staphylococcus_aureus_mrsa_bacteria2
Methicillin resistant Staphylococcus aureus

From cradle to grave, antimicrobials have become pivotal in safeguarding the overall health of human societies. According to the World Health Organization (WHO), antimicrobial resistance (AMR) is one of the biggest threats to global health today. Recently, at the United Nations, World Heads of State committed to taking a broad, coordinated approach to address the root causes of AMR across multiple sectors, especially human health, animal health and agriculture, only the fourth time that a health issue has been taken up by the UN General Assembly. According to the O’Neill report, it is estimated that 700,000 people die annually from drug resistant infections. In the US alone, more than two million infections a year are caused by bacteria resistant to at least one antibiotic, costing the US health system more than US$20 billion in excess costs annually. Continue reading